| 7:15 a.m. | Continental Breakfast – Posters Available |
| 8:00 a.m. | Welcome from the ATS President - Raed A. Dweik, MD, MBA, ATSF, Cleveland Clinic Health System
|
| 8:10 a.m. | Co-Chair Address: State of Innovation and Investment - Craig Conoscenti, MD, ATSF – Senior Vice President, Avalyn Pharma, Inc.
- Niall O’Donnell, PhD, MA, MBA – Managing Director, RiverVest
|
| 8:30 a.m. | Showcase One: Breakthroughs in Critical Care - Moderator: Courtney Crim, MD, ATSF
- GEn1E Lifesciences Inc. – Ritu Lal Ph.D., M.S. (Management), CEO and Co-founder
- Herald Therapeutics – David H Ingbar, MD, Professor (UMN), Chief Scientific Officer
- Iff Technologies – Samarth Sandeep Chief Executive Officer
- NuvOx Therapeutics Inc. – Rong Wang President and Chief Executive Officer
- Tessara Bio – Jahar Bhattacharya, DPhil, Scientific Co-Founder and Research Lead
|
| 9:00 a.m. | Panel: Investor Discussion - Moderator: Niall O’Donnell, PhD, MA, MBA – Managing Director, RiverVest
- Leighanne Oh, MS, Biotech Investor, Ascenta Capital
- Ksenyia Simpson, PhD, Partner, Hatteras Venture Partners
- Justin Zhang, Biotech VC, Norwest Venture Partners
- Drew Cutshaw, Principal, Pappas Capital
- Court Turner, Partner, LYZZ Capital Advisors
|
| 9:45 a.m. | Networking Break – Posters Available |
| 10:15 a.m. | Showcase Two: Reimagining Chronic Respiratory Care - Moderator: Charles Powell, MD, MBA, Division Chief, Icahn School of Medicine
- Altesa BioSciences, Inc. – Katherine Squires, PhD, Vice President of Preclinical Development
- CareCentra Inc. – Vasant Kumar Ramaswamy MBA, Founder & Chief Executive Officer
- Kymera Therapeutics – Michael Feldman MD, PhD Executive Medical Director
- Noze Inc. – Karim Aly, MBA, Chief Executive Officer
- SMSbiotech – Abdulkader Rahmo, PhD, Chief Scientific Officer and Founder
- Synchrony Medical - Anat Shani, BSc, MBA, Co-Founder and Chief Executive Officer
|
| 10:45 a.m. | Panel: Smarter Signals - How Innovative Endpoints Are Changing the Drug Development Pathway - Moderator: Doreen Miao, PhD, Vice President, Marketing & Strategic Development, THORASYS
- Adam LaPrad, PhD, Chief Scientific & Product Officer, ZEPHYRx
- Bina Choi, MD, MPH, Medical Lead, Sanofi
- Glenn Crater, MD, Chief Medical Officer, Innospera Pharma
- Jan De Backer, PhD, Chief Executive Officer, Fluidda
|
| 11:30 a.m. | Showcase Three: Cracking the Code of Lung Fibrosis - Moderator: Joseph Reif, MBA, Vice President, Clinical & Business Development, VIDA Diagnostics
- Calluna Pharma – Mark Gaffney, JD, Chief Executive Officer
- Duke Clinical Research Institute – Scott Palmer, MD, Professor of Medicine
- MannKind Corporation – Wassim Fares, MD, MSc, Senior Vice President, Orphan Lung Therapeutic Area Head
- Polarean – Alex Dusek Chief Business Officer
- Sunterra Bio Inc. – Michael Hy, Founder, Chief Executive Officer
|
| 12:00 p.m. | Lunch – Posters Available |
| 1:00 p.m. | Panel: Business Development - Moderator: Mark Dowling, head, external innovation, Sanofi
- Syed Moinuddin, senior director, US Business Development and Strategic Partnerships, GSK
- Moustapha Elamine, PhD, MSc, MBA, vice president, head of business development, Insmed
- David Blair, PhD, director, Strategic Partnering (Immunology), Global BD&L, Boehringer-Ingelheim
- Richard Strakosch, business development lead, Genentech
|
| 1:45 p.m. | Showcase Four: Technology Transforming Respiratory Science - Moderator: Tom Salemi – Editorial Director, DeviceTalks
- Cincinnati Children's Hospital – Qiwei Xiao, PhD, MSc, Research Faculty
- Lungpacer Medical – Doug Evans, MS, MBA, Chief Executive Officer
- O2matic – Marie-Louise Little, MSc, Chief Executive Officer
- Qnovia, Inc. – Mario Danek, Founder, Chief Executive Officer
|
| 2:30 p.m. | Networking Break – Posters Available |
| 3:00 p.m. | Showcase Five: The Emerging Science of Lung Disease - Moderator Ted Witek, DrPH, MBA, ATSF, Professor & Senior Fellow, University of Toronto
- Eupnoos – Deepak Kotak MBBS, MA, Chief Medical Officer
- Open Source Imaging Consortium (OSIC) – Elizabeth Estes, Executive Director
- Rabble Health Inc. – Aubrey Kelly, MS, MBA, Founder and Chief Executive Officer
- ReCode Therapeutics – John Matthews, PhD, MBBS, MRCP, Chief Medical Officer
- RNATICS – Klaus Rabe, MD, PhD, Director of Airway Research Center North (ARCN)
|
| 3:30 p.m. | RIS Featured Success Story - Insilico Medicine – Carol Satler MD, PhD, Senior Vice President Clinical Development
|
| 3:45 p.m. | Showcase Six: The Future of Lung Health - Moderator: Craig Conoscenti, MD, ATSF – Senior Vice President, Avalyn Pharma, Inc.
- Alveolus Bio Inc. – Ahmed Abdelgawad, MD, MS, MBA, Research Scientist, UAB
- Synapse Biomedical Inc. – Raymond Onders MD, Chair of Surgical Innovation
- BioNAV Environmental Health – Robert Freeman, Founder and Chief Executive Officer
- TrilliumBiO – Aamir Ali, MD, Chief Medical Officer
- Vicore Pharma – Ahmed Mousa, JD, MS, Chief Executive Officer
- Generate Biomedicines – Amit Parulekar MD, MS, MBA, ATSF, Senior Director, Clinical Development
|
| 4:30 p.m. | Closing Remarks and Sponsor Recognition - Craig Conoscenti, MD, ATSF – Senior Vice President, Avalyn Pharma, Inc.
- Niall O’Donnell, PhD, MA, MBA – Managing Director, RiverVest
|
| 4:45 p.m. | Networking Reception – Posters Available |
| 6:00 p.m. | Adjourn |
